Clinical trial
Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg
NCT01367054 is registered in ClinicalTrials.gov with Biocinese as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg
- Lead sponsor
- Biocinese
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2008
- Completion date
- December 31, 2011
- Enrollment
- 26 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.